Of course. Here is a thorough critique and revised valuation of Rollins, Inc. (ROL), addressing the issues in the original analysis while maintaining the requested format.

### **Critique of Original Valuation**

The original analysis is well-structured and follows a logical DCF process. However, it contains one critical flaw that leads to an overly conservative valuation:

*   **Terminal Value Disconnect:** The primary issue lies in the Terminal Value (Part F). The analysis correctly calculates that a 2.5% perpetuity growth rate implies a terminal EV/EBITDA multiple of **15.8x**. It then correctly observes that Rollins has historically traded at a premium, often exceeding **20x**. The logical inconsistency is concluding that the 15.8x multiple is "realistic." For a high-quality, market-leading company with recurring revenue like Rollins, a sudden and permanent de-rating from its historical premium to a market-average multiple is an unnecessarily bearish assumption. This single assumption is the primary driver of the low valuation of $31.77.

The rest of the analysis, including the reverse DCF, the 5-year operating assumptions, and the WACC calculation, are reasonable and provide a solid foundation. The fix will focus almost exclusively on deriving a more realistic terminal value.

***

### **Revised Valuation Analysis: Rollins, Inc. (ROL)**

*   **Company:** Rollins, Inc.
*   **Ticker:** ROL
*   **Currency:** USD
*   **Date of Analysis:** August 24, 2025
*   **Primary Sources Reviewed:** SEC Filings (10-K, 10-Q), StockAnalysis.com for aggregated financial data, and public data for market inputs.

***

### **Part 1: Market-Implied Valuation (Reverse DCF)**

This section deduces the growth and profitability assumptions embedded in the current stock price.

**A) Establish Baseline & Market Price**

1.  **Current Market Price:** The current market price for Rollins, Inc. (ROL) is **$58.23** (QuoteMedia, August 22, 2025, 9:38 AM EDT).

2.  **Baseline Financials (TTM):** Based on the latest financial data, the following table summarizes Rollins' TTM financials as of the quarter ended June 30, 2025.

| Metric | Amount (in millions USD) | Source & Citation |
| :--- | :--- | :--- |
| Revenue | $3,570 | (StockAnalysis, June 30, 2025) |
| Operating Income (EBIT) | $683.4 | (StockAnalysis, June 30, 2025) |
| Depreciation & Amortization | $119.1 | (StockAnalysis, June 30, 2025) |
| Stock-Based Compensation | $34.2 | (StockAnalysis, June 30, 2025) |
| Capital Expenditures | $25.6 | (StockAnalysis, June 30, 2025) |
| Change in Working Capital | $20.2 | (StockAnalysis, June 30, 2025) |
| Cash & Equivalents | $123.0 | (StockAnalysis, June 30, 2025) |
| Total Debt | $967.2 | (StockAnalysis, June 30, 2025) |
| Diluted Shares Outstanding | 484.4 | (StockAnalysis, June 30, 2025) |

**B) Reverse-Engineer Assumptions**

*   **Preliminary WACC Calculation:**
    *   Risk-Free Rate: 2.8%
    *   Equity Risk Premium: 5.5%
    *   Beta: 0.8
    *   Cost of Equity: 2.8% + 0.8 * 5.5% = **7.2%**
    *   Cost of Debt (pre-tax): 2.6%
    *   Tax Rate: 25.8%
    *   After-Tax Cost of Debt: **1.9%**
    *   Market Capitalization: $28,206M
    *   WACC = **7.0%** (approx.)

*   **Implied Growth Calculation:**
    Holding the TTM operating margin of 19.1% constant and using a 2.5% terminal growth rate, the model requires a **5-year revenue CAGR of approximately 14.5%** to arrive at the current market price of $58.23.

**Conclusion for Part 1:** To justify the current stock price of $58.23, an investor must believe that Rollins, Inc. can grow its revenue at a compounded annual rate of **14.5%** for the next five years, while maintaining its current operating margin of **19.1%**. This serves as a useful, albeit high, benchmark.

---

### **Part 2: Analyst's Revised Valuation (Realistic Base-Case)**

This section builds a valuation based on independent assumptions grounded in historical performance, management commentary, and sector realities.

**C) Formulate Conservative Assumptions (5 Years)**

6.  **Critical Review:** The market-implied growth rate of 14.5% appears optimistic. The following assumptions for the explicit 5-year forecast period are designed to be prudent and realistic.

7.  **Revenue (Years 1â€“5):** A growth rate starting at **10% in Year 1 and tapering down by 1% each year to 6% in Year 5** is a reasonable base case. This reflects moderation from strong recent performance towards a more mature growth rate.

8.  **Margin Path:** Assume the **operating margin remains stable at the 3-year average of 19.2%** throughout the forecast period, reflecting operational consistency.

9.  **Taxes:** Use a **26.0% effective tax rate**, consistent with the three-year historical average.

10. **Capital Intensity:**
    *   **Capex:** Assume **capex remains at 0.8% of revenue**.
    *   **Working Capital:** Model the Change in Net Working Capital as **1.0% of incremental revenue**.

11. **SBC, Dilution, and Buybacks:**
    *   **Stock-Based Compensation (SBC):** Model SBC at **1.0% of revenue.**
    *   **Share Count:** Assume a **net 0.0% annual change** in the 484.4 million diluted shares.

**D) Free Cash Flow Construction**

**FCFF = EBIT * (1 - Tax Rate) + D&A - SBC - Capex - Change in Working Capital**

Here is the 5-year FCFF build based on the assumptions (all figures in millions USD):

| Year | 1 | 2 | 3 | 4 | 5 |
| :--- | :--- | :--- | :--- | :--- | :--- |
| Revenue | $3,927.0 | $4,280.4 | $4,622.9 | $4,946.5 | $5,243.2 |
| EBIT (19.2%) | $754.0 | $821.8 | $887.6 | $949.7 | $1,006.7 |
| NOPAT | $557.9 | $608.2 | $656.8 | $702.8 | $745.0 |
| D&A (3.3% of Rev) | $129.6 | $141.3 | $152.6 | $163.2 | $173.0 |
| Stock-Based Comp | ($39.3) | ($42.8) | ($46.2) | ($49.5) | ($52.4) |
| Capex | ($31.4) | ($34.2) | ($37.0) | ($39.6) | ($41.9) |
| Change in NWC | ($3.6) | ($3.5) | ($3.4) | ($3.2) | ($3.0) |
| **Free Cash Flow** | **$613.2** | **$669.0** | **$722.8** | **$773.7** | **$820.7** |

**E) Discount Rate (WACC)**

14. **Cost of Equity (CAPM):**
    *   Risk-Free Rate: **2.8%**
    *   Equity Risk Premium: **5.5%**
    *   Beta: **0.8**
    *   **Cost of Equity = 2.8% + 0.8 * 5.5% = 7.2%**

15. **Cost of Debt:**
    *   Pre-Tax Cost of Debt: 2.6%.
    *   After-Tax Cost of Debt = 2.6% * (1 - 26.0%) = **1.9%**.

16. **WACC Calculation:**
    *   Using current market values for weighting:
    *   **WACC = ($28,206/$29,173 * 7.2%) + ($967.2/$29,173 * 1.9%) = 7.0%**

**F) Terminal Value**

17. **Method Selection: Exit Multiple:** The Gordon Growth method's implied 15.8x EV/EBITDA multiple is inconsistent with Rollins' historical valuation premium, which is deserved due to its resilient, recurring revenue model and market leadership. Therefore, the **Exit Multiple method is more appropriate**. We will select a multiple that reflects a slight normalization from current levels but still acknowledges the company's superior quality. A base-case **terminal EV/EBITDA multiple of 21.0x** is chosen. This is below recent highs but well above the generic market average, striking a realistic balance.

18. **Terminal Value Calculation:**
    *   Year 5 EBIT = **$1,006.7M**
    *   Year 5 D&A = **$173.0M**
    *   Year 5 EBITDA = $1,006.7M + $173.0M = **$1,179.7M**
    *   **Terminal Value = Year 5 EBITDA * Exit Multiple**
    *   **Terminal Value = $1,179.7M * 21.0 = $24,773.7M**

19. **Implied Growth Cross-Check:** This terminal value implies a perpetuity growth rate `g`.
    *   `g = (WACC * TV - FCFF_5) / (TV + FCFF_5)`
    *   `g = (7.0% * $24,773.7M - $820.7M) / ($24,773.7M + $820.7M) = 3.55%`
    *   An implied long-term growth rate of 3.55% is higher than a simple inflation proxy but is justifiable for a market leader that consistently grows via acquisition and price increases. This cross-check validates the 21.0x multiple as reasonable.

**G) Enterprise to Equity Bridge**

20. **Enterprise Value:**
    *   PV of Explicit FCFF = $613.2/(1.07)^1 + $669.0/(1.07)^2 + $722.8/(1.07)^3 + $773.7/(1.07)^4 + $820.7/(1.07)^5 = **$2,911.7M**
    *   PV of Terminal Value = $24,773.7M / (1.07)^5 = **$17,663.2M**
    *   **Enterprise Value = $2,911.7M + $17,663.2M = $20,574.9M**

21. **Equity Value:**
    *   Net Debt = Total Debt ($967.2M) - Cash ($123.0M) = **$844.2M**
    *   **Equity Value = $20,574.9M - $844.2M = $19,730.7M**

**H) Per-Share Value and Margin of Safety**

22. **Analyst's Base-Case Fair Value:**
    *   **Fair Value Per Share = $19,730.7M / 484.4M shares = $40.73**

23. **Valuation Range:**
    *   **Base Case: $40.73.** As calculated, using a 21.0x terminal multiple.
    *   **Low/Bear Case: $35.50.** Assumes lower growth and a lower terminal multiple of 18.0x, reflecting increased competition or M&A slowdown.
    *   **High/Bull Case: $46.00.** Assumes slightly better growth (e.g., tapering to 7%) and a higher terminal multiple of 23.0x, reflecting continued strong market leadership.

24. **Margin of Safety (MOS) Price:**
    *   A 30% margin of safety from the base-case estimate provides a target purchase price.
    *   **MOS Price = $40.73 * (1 - 0.30) = $28.51**

### **Risk Notes**

The key risks to this valuation thesis include: 1) **Regulatory Scrutiny:** Increased environmental regulations on pesticides could raise compliance costs or ban effective treatments. 2) **M&A Integration:** Rollins relies on acquiring smaller operators for growth; overpaying or failing to integrate these acquisitions could destroy value. 3) **Reputational Damage:** A high-profile service failure (e.g., environmental contamination, pest control failure causing property damage) could harm the brand and lead to customer loss. 4) **Valuation Risk:** The company consistently trades at a premium multiple. A shift in market sentiment towards value could cause a significant de-rating, even if business fundamentals remain strong.

final answer is 40.73 $